Publications GFPC 2021

Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer – Secondary analysis of the randomised pahse 3 CONVERT trial.


Lung Cancer.2021 Mar 153:165-170.

Lien: 10.1016/j.lungcan.2020.03.006


Fabio GomesCorinne Faivre-FinnHitesh MistryAndrea BezjakNicolas PourelPierre FournelJan Van MeerbeeckFiona Blackhall 



Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis


Ther Adv Med Oncol 2021, Vol. 13: 1– 10




Isabelle Monnet, Alain Vergnenègre, Gilles Robinet, Henri Berard, Regine Lamy, Lionel Falchero, Sabine Vieillot, Roland Schott, Charles Ricordel, Stephane Chouabe, Pascal Thomas, Radj Gervais, Anne Madroszyk, Samir Abdiche, Anne Marie Chiappa,Laurent Greillier, Chantal Decroisette, Jean Bernard Auliac and Christos Chouaïd



First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50%




Renaud Descout, Christos Chouaid, Maurice Perol, Benjamin Besse, Laurent Greillier, Olivier Bylicki, Charles Ricordel, Florian Guisier, Radj Gervais, Roland Schott, Jean-Bernard Auliac, Gilles Robinet & Chantal Decroisette



Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC02–15 study)




Jean-Bernard Auliac, Isabelle Monnet, Acya Bizieux, Laurent Greillier, Margaux Geier, Lionel Falchero, Gwenaelle Le Garff, Regine Lamy, Florian Guisier, Charles Ricordel, Christos Chouaid, Alain Vergnenegre, REFRACT GFPC 02-15 investigators



Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)




Isabelle Martel-Lafay, Isabelle Monnet, Audrey Lardy-Cleaud, Serge Danhier, Naji Salem, Olivier Gallocher, Pierre Fournel, Christos Chouaid , Olivier Bylicki and the GFPC 01-14 Investigators



Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 study


http://DOI: 10.4103/jcrt.JCRT_784_20




Nicolas Paleiron, Radj Gervais, Gaelle Rousseau-Bussac, Laurence Bigay Game, Anne Marie Chiappa, Regine Lamy, Florian Guisier, Hervé Le Caer, Gilles Robinet, Acya Bizieux, Christos Chouaïd, GFPC